Trial Information
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma: A Multicenter, Prospective, Randomized Trial
Inclusion Criteria:
- FIGO stage: ⅠA, endometrial carcinoma;
- Female, Chinese women;
- premenopausal women;
- ≤ 50 years old;
- Pathological diagnosis by curettage/hysteroscopy : G1
- No prior treatment;
- Provide written informed consent.
Exclusion Criteria:
- The suspicious metastasis of ovarian;
- Family history of ovarian cancer;
- Suffering from other malignancies;
- Concurrently participating in other clinical trials;
- Unable or unwilling to sign informed consents;
- Unable or unwilling to abide by protocol.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Disease-free survival (DFS)
Outcome Time Frame:
3-year DFS
Safety Issue:
No
Principal Investigator
Beihua Kong, MD, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
Shandong University
Authority:
China: Ministry of Health
Study ID:
2012-GYN/EC-02
NCT ID:
NCT01820884
Start Date:
November 2012
Completion Date:
December 2017
Related Keywords:
- Endometrial Neoplasms
- Neoplasms
- Carcinoma
- Endometrial Neoplasms
- Adenoma